Anteris Technologies Global Corp. aims to raise $75 million in an IPO for aortic stenosis treatment development in a growing ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development ...

which is anticipated to offer fresh insights for global implanters treating symptomatic severe aortic stenosis (SASS). The ...

A recent study has revealed a strong link between insulin resistance and an increased risk of aortic stenosis (AS), a ...

Insulin resistance can increase the risk of aortic stenosis -- a common heart valve disease -- in men over the age of 45, ...

In the CONDUCT-TAVI study, the use of a self-expanding valve was not associated with an increased risk of pacemaker.

Insulin resistance associated with prediabetes appears to raise a person’s risk of a common and serious heart valve ...

Medtronic announced the launch of its ALERT study, which aims to address racial, ethnic, gender and geographic disparities in ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic ...